Become a Member
Dark Mode
Become a Member
Uncovering Hate
WebQoof
Naukri Crisis
Scamguard
Climate Change
Raghav's Take
My Report
Opinion
Members Only
More
Brand Studio
World
Politics
Explainers
Videos
Entertainment
The Quint Lab
Sports
Gender
More
Education
Podcasts
Kaafi Real
Special Projects
Members' Opinion
Dark Mode
Become a Member
Home
Naukri Crisis
Scamguard
Uncovering Hate
Special Projects
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
Covaxin Efficacy
Covaxin Has 77.8% Efficacy Against COVID: Phase 3 Data in the Lancet
Covaxin Effective Against Delta Plus Covid Variant: ICMR Study
ADVERTISEMENT
REMOVE AD
Covaxin Has 77.8% Efficacy Against COVID: Phase 3 Data in the Lancet
Covaxin Effective Against Delta Plus Covid Variant: ICMR Study
Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel
Covaxin COVID Vaccine 77.8% Effective; 10 Things to Know About the Phase 3 Data
'Covaxin Has 77.8% Efficacy in Phase 3': What Do We Know So Far?
